Adverse outcomes after major surgery in patients with systemic lupus erythematosus: A nationwide population-based study

Annals of the Rheumatic Diseases

Volumn 73, Issue 9, 2014, Pages 1646-1651

  Lin, Jui An ^a,b,c   Liao, Chien Chang ^a,b   Lee, Yi Jui ^a,b   Wu, Chih Hsiung ^b   Huang, Wen Qi ^d   Chen, Ta Liang ^a,b  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH SERVICES RESEARCH; OUTCOMES RESEARCH; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; GLUCOCORTICOIDS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK ASSESSMENT; SEX DISTRIBUTION; TAIWAN; YOUNG ADULT;

EID: 84905160666     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202758     Document Type: Article

References (46)

1. D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 2007;369:587-96. (Pubitemid 46241445)
2. Serdula MK, Rhoads GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 1979;22:328-33. (Pubitemid 10141616)
3. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15:308-18. (Pubitemid 43828810)
4. Osio-Salido E, Manapat-Reyes H. Epidemiology of systemic lupus erythematosus in Asia. Lupus 2010;19:1365-73.
5. Schattner A, Liang MH. The cardiovascular burden of lupus: a complex challenge. Arch Intern Med 2003;163:1507-10. (Pubitemid 36835093)
6. Urowitz MB, Bookman AA, Koehler BE, et al. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5.
7. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008;358:929-39. (Pubitemid 351397092)
8. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 1975;58:243-64.
9. Ward MM, Pajevic S, Dreyfuss J, et al. Short-term prediction of mortality in patients with systemic lupus erythematosus: classification of outcomes using random forests. Arthritis Rheum 2006;55:74-80. (Pubitemid 43235130)
10. Petri M, Perez-Gutthann S, Longenecker JC, et al. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991;91:345-53.
11. Papa MZ, Shiloni E, Vetto JT, et al. Surgical morbidity in patients with systemic lupus erythematosus. Am J Surg 1989;157:295-8. (Pubitemid 19074557)
12. Badsha H, Edwards CJ. Intravenous pulses of methylprednisolone for systemic lupus erythematosus. Semin Arthritis Rheum 2003;32:370-7. (Pubitemid 36759364)
13. Lin JA, Liao CC, Chang CC, et al. Postoperative adverse outcomes in intellectually disabled surgical patients: a nationwide population-based study. PLoS One 2011;6:e26977.
14. Cheng CL, Kao YH, Lin SJ, et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011;20:236-42.
15. Liao CC, Shen WW, Chang CC, et al. Surgical adverse outcomes in patients with schizophrenia: a population-based study. Ann Surg 2013;257:433-8.
16. Chen YJ, Chang YT, Wang CB, et al. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med 2010;123:1150.e1-6.
17. Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009;361:1368-75.
18. Khuri SF, Henderson WG, DePalma RG, et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg 2005;242:326-41.
19. Chang CC, Hu CJ, Lam F, et al. Postoperative adverse outcomes in surgical patients with epilepsy: a population-based study. Epilepsia 2012;53:987-94.
20. Hu CJ, Liao CC, Chang CC, et al. Postoperative adverse outcomes in surgical patients with dementia: a retrospective cohort study. World J Surg 2012;36:2051-8.
21. Krishnan E. Hospitalization and mortality of patients with systemic lupus erythematosus. J Rheumatol 2006;33:1770-4. (Pubitemid 44373209)
22. Liang JA, Sun LM, Yeh JJ, et al. Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study. Rheumatol Int 2012;32:773-8.
23. Lin YC, Liang SJ, Liu YH, et al. Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. Rheumatol Int 2012;32:1669-73.
24. Cohen MG, Webb J. Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases. Ann Rheum Dis 1987;46:853-8. (Pubitemid 17155440)
25. Engelman E, Maeyens C. Effect of preoperative single-dose corticosteroid administration on postoperative morbidity following esophagectomy. J Gastrointest Surg 2010;14:788-804.
26. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550-7. (Pubitemid 44205016)
27. Subramanian V, Saxena S, Kang JY, et al. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 2008;103:2373-81.
28. Lockhart PB, Brennan MT, Fox PC, et al. Decision-making on the use of antimicrobial prophylaxis for dental procedures: a survey of infectious disease consultants and review. Clin Infect Dis 2002;34:1621-6. (Pubitemid 34615448)
29. Koh ET, Seow A, Leong KH, et al. SLE mortality in an oriental population. Lupus 1997;6:27-31. (Pubitemid 27055732)
30. Kim WU, Min JK, Lee SH, et al. Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study. Clin Exp Rheumatol 1999;17:539-45.
31. Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) 1987;66:341-8. (Pubitemid 18020233)
32. Kinder BW, Freemer MM, King TE Jr., et al. Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. Arthritis Rheum 2007;56:2679-86. (Pubitemid 47237286)
33. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996;156:1337-44. (Pubitemid 26196894)
34. Baer HJ Jr., Winer RL. Renal cortical necrosis in systemic lupus erythematosus. South Med J 1984;77:81-3. (Pubitemid 14183657)
35. Glueck HI, Kant KS, Weiss MA, et al. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985;145:1389-95. (Pubitemid 15049790)
36. Ponticelli C, Imbasciati E, Brancaccio D, et al. Acute renal failure in systemic lupus erythematosus. BMJ 1974;3:716-19.
37. Hughson MD, Nadasdy T, McCarty GA, et al. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 1992;20:150-8.
38. Kellerman PS, Leek JC. Renal thrombotic microangiopathy mimicking active SLE nephritis. Nephrol Dial Transplant 1994;9:1482-5. (Pubitemid 24310296)
39. Asanuma Y, Oeser A, Shintani AK, et al . Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2407-15. (Pubitemid 37542989)
40. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406. (Pubitemid 37542988)
41. Wilson PW. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. Am J Med 2008;121:S15-20.
42. Asherson RA, Cervera R. Review: antiphospholipid antibodies and the lung. J Rheumatol 1995;22:62-6.
43. Ramagopalan SV, Wotton CJ, Handel AE, et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011;9:1.
44. Sweetland S, Green J, Liu B, et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 2009;339:b4583.
45. D'Cruz DP. Systemic lupus erythematosus. BMJ 2006;332:890-4. (Pubitemid 44365587)
46. Hill J, Treasure T. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ 2010;340:c95.